HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637HAD1. A total of 51 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $110,468,006 | +120.1% | 128,679,626 | +115.5% | 5.49% | +34.4% |
| Q2 2023 | $50,184,506 | -16.9% | 59,699,359 | -15.7% | 4.08% | -8.4% |
| Q1 2023 | $60,420,911 | +80366.8% | 70,776,482 | +91298.8% | 4.46% | -12.3% |
| Q4 2022 | $75,088 | -99.9% | 77,437 | -13.1% | 5.08% | -6.0% |
| Q3 2022 | $76,268,000 | -7.0% | 89,152 | -3.4% | 5.41% | -1.4% |
| Q2 2022 | $82,027,000 | +28.9% | 92,289 | +29.2% | 5.48% | +26.7% |
| Q1 2022 | $63,617,000 | – | 71,432 | – | 4.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 128,679,626 | $110,468,006 | 5.49% |
| CAMDEN ASSET MANAGEMENT L P /CA | 77,223,000 | $65,160,767 | 2.42% |
| Penn Mutual Asset Management | 1,555,000 | $1,312,109 | 1.23% |
| ZAZOVE ASSOCIATES LLC | 9,108,000 | $7,715,000 | 0.80% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 50,000,000 | $42,190,000 | 0.67% |
| LAFFER TENGLER INVESTMENTS, INC. | 2,399 | $2,032,823 | 0.60% |
| SHENKMAN CAPITAL MANAGEMENT INC | 9,019,000 | $7,767,672 | 0.58% |
| LINDEN ADVISORS LP | 62,930,000 | $53,329,425 | 0.55% |
| SSI INVESTMENT MANAGEMENT LLC | 4,577,000 | $3,862,074 | 0.32% |
| Sonora Investment Management Group, LLC | 4,355,000 | $3,675,060 | 0.31% |